{"pmid":32478942,"title":"Covid-19 infection in psoriasis patients treated with cyclosporin.","text":["Covid-19 infection in psoriasis patients treated with cyclosporin.","Dermatol Ther","Di Lernia, V","Goldust, M","Feliciani, C","32478942"],"journal":"Dermatol Ther","authors":["Di Lernia, V","Goldust, M","Feliciani, C"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32478942","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1111/dth.13739","e_drugs":["Cyclosporine"],"topics":["Prevention"],"weight":1,"_version_":1668532089532710912,"score":9.490897,"similar":[{"pmid":32487139,"title":"Cyclosporine A: a valid candidate to treat COVID-19 patients with acute respiratory failure?","text":["Cyclosporine A: a valid candidate to treat COVID-19 patients with acute respiratory failure?","Crit Care","Cour, Martin","Ovize, Michel","Argaud, Laurent","32487139"],"journal":"Crit Care","authors":["Cour, Martin","Ovize, Michel","Argaud, Laurent"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32487139","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1186/s13054-020-03014-1","e_drugs":["Cyclosporine"],"topics":["Treatment"],"weight":1,"_version_":1668623433545547777,"score":54.413795},{"pmid":32314483,"title":"COVID-19 and psoriasis: Should we fear for patients treated with biologics?","text":["COVID-19 and psoriasis: Should we fear for patients treated with biologics?","The new coronavirus pandemic poses question and challenges for dermatologists. One of question is if psoriasis patients treated with immunomodulating and immunosuppressive drugs have to discontinue their treatment in the midst of fears for the infection and its consequences. One of the challenges is how can we support our patients in this critical time. Previous coronaviruses outbreaks reports, current published evidences on pathogenesis and on clinical reports of COVID infection in immunosuppressed patients are used to make a scientifically based decision.","Dermatol Ther","Amerio, Paolo","Prignano, Francesca","Giuliani, Federica","Gualdi, Giulio","32314483"],"abstract":["The new coronavirus pandemic poses question and challenges for dermatologists. One of question is if psoriasis patients treated with immunomodulating and immunosuppressive drugs have to discontinue their treatment in the midst of fears for the infection and its consequences. One of the challenges is how can we support our patients in this critical time. Previous coronaviruses outbreaks reports, current published evidences on pathogenesis and on clinical reports of COVID infection in immunosuppressed patients are used to make a scientifically based decision."],"journal":"Dermatol Ther","authors":["Amerio, Paolo","Prignano, Francesca","Giuliani, Federica","Gualdi, Giulio"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32314483","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1111/dth.13434","keywords":["covid-19","sars","biologics","psoriasis","therapy"],"topics":["Treatment"],"weight":1,"_version_":1666138493540106240,"score":45.15991},{"pmid":32376422,"pmcid":"PMC7196541","title":"Cyclosporine therapy during the COVID-19 pandemic is not a reason for concern.","text":["Cyclosporine therapy during the COVID-19 pandemic is not a reason for concern.","J Am Acad Dermatol","Rudnicka, Lidia","Goldust, Mohamad","Glowacka, Paulina","Sikora, Mariusz","Sar-Pomian, Marta","Rakowska, Adriana","Samochocki, Zbigniew","Olszewska, Malgorzata","32376422"],"journal":"J Am Acad Dermatol","authors":["Rudnicka, Lidia","Goldust, Mohamad","Glowacka, Paulina","Sikora, Mariusz","Sar-Pomian, Marta","Rakowska, Adriana","Samochocki, Zbigniew","Olszewska, Malgorzata"],"date":"2020-05-08T11:00:00Z","year":2020,"_id":"32376422","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.jaad.2020.04.153","keywords":["covid-19","autoimmune disease","cyclosporine","dermatology","immunosuppressants","virus"],"e_drugs":["Cyclosporine"],"topics":["Treatment"],"weight":1,"_version_":1666596532358479872,"score":44.91754},{"pmid":32354685,"pmcid":"PMC7160056","title":"Why Choose Cyclosporin A as First-line Therapy in COVID-19 Pneumonia.","text":["Why Choose Cyclosporin A as First-line Therapy in COVID-19 Pneumonia.","Reumatol Clin","Sanchez-Pernaute, Olga","Romero-Bueno, Fredeswinda I","Selva-O'Callaghan, Albert","32354685"],"journal":"Reumatol Clin","authors":["Sanchez-Pernaute, Olga","Romero-Bueno, Fredeswinda I","Selva-O'Callaghan, Albert"],"date":"2020-05-02T11:00:00Z","year":2020,"_id":"32354685","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.reuma.2020.03.001","locations":["Pneumonia"],"e_drugs":["Cyclosporine"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1666138495179030529,"score":42.60405}]}